Patent holdings for IPC class A61P 37/00

Total number of patents in this class: 8763

10-year publication summary

332
354
491
638
656
605
741
680
601
243
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Mondobiotech Laboratories AG
311
290
Bristol-myers Squibb Company
4892
146
F. Hoffmann-La Roche AG
7926
131
Novartis AG
10904
119
Genentech, Inc.
3961
75
Incyte Corporation
1011
74
Boehringer Ingelheim International GmbH
4704
60
Hoffmann-La Roche Inc.
3379
58
Merck Patent GmbH
5850
51
Inserm (institut National de La Sante et de La Recherche Medicale)
3360
48
Glaxo Group Limited
4132
43
Takeda Pharmaceutical Company Limited
2704
42
AstraZeneca AB
2928
41
Janssen Pharmaceutica N.V.
3423
40
The Regents of the University of California
19812
39
Glaxosmithkline Intellectual Property Development Limited
753
39
Shanghai Hengrui Pharmaceutical Co., Ltd.
628
35
Jiangsu Hengrui Medicine Co., Ltd.
706
34
Bayer Pharma AG
1061
33
Sanofi
4009
31
Other owners 7334